• 1. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 2. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 3. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 4. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 5. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzyl alcohols
• Solvents and Organic Chemicals Organic Compounds Alcohol/Ether

Professional Introduction to 2,6-Difluoro-4-hydroxybenzyl alcohol (CAS No: 438049-36-6)

2,6-Difluoro-4-hydroxybenzyl alcohol, identified by the Chemical Abstracts Service Number (CAS No) 438049-36-6, is a fluorinated aromatic alcohol that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound, characterized by its distinct structural features—specifically the presence of two fluorine atoms at the 2- and 6-positions of the benzene ring and a hydroxyl group at the 4-position—exhibits unique chemical and biological properties that make it a promising candidate for various applications in drug discovery and development.

The structural motif of 2,6-Difluoro-4-hydroxybenzyl alcohol positions it as a derivative of hydroxybenzyl alcohols, a class of compounds known for their versatility in medicinal chemistry. The introduction of fluorine atoms into the aromatic ring system not only modifies electronic and steric properties but also enhances metabolic stability, lipophilicity, and binding affinity to biological targets. These attributes are particularly valuable in the design of small-molecule inhibitors and modulators targeting enzymes and receptors involved in critical biological pathways.

In recent years, there has been a surge in research focused on fluorinated aromatic compounds due to their ability to improve pharmacokinetic profiles of drug candidates. The fluorine atoms in 2,6-Difluoro-4-hydroxybenzyl alcohol contribute to its favorable pharmacological properties by increasing binding affinity through hydrophobic interactions and reducing susceptibility to enzymatic degradation. This has made it an attractive scaffold for the development of novel therapeutic agents.

One of the most compelling aspects of 2,6-Difluoro-4-hydroxybenzyl alcohol is its potential application in the synthesis of bioactive molecules. Its hydroxyl group provides a reactive site for further functionalization, enabling the construction of more complex structures with tailored biological activities. For instance, researchers have explored its use in generating derivatives with enhanced binding to protein targets, such as kinases and transcription factors, which are key players in diseases like cancer and inflammatory disorders.

Recent studies have highlighted the role of fluorinated phenols like 2,6-Difluoro-4-hydroxybenzyl alcohol in modulating enzyme activity. A notable example comes from research on tyrosine kinases, where fluorinated analogs have demonstrated improved selectivity and potency compared to their non-fluorinated counterparts. The electron-withdrawing effect of fluorine atoms helps stabilize transition states during catalysis, thereby enhancing inhibitory effects on target enzymes. This principle has been leveraged to develop novel inhibitors with therapeutic potential.

The hydroxyl group in 2,6-Difluoro-4-hydroxybenzyl alcohol also facilitates its incorporation into larger molecular frameworks through various chemical transformations. For example, etherification or esterification reactions can be employed to introduce additional functional groups or linkages, expanding its utility in drug design. Such modifications are crucial for optimizing pharmacokinetic properties and improving oral bioavailability.

In addition to its role as an intermediate in drug synthesis, 2,6-Difluoro-4-hydroxybenzyl alcohol has shown promise as a building block for probe compounds used in biochemical assays. Its well-defined structure allows researchers to develop selective tools for studying enzyme mechanisms and pathway interactions. By leveraging its unique chemical properties, scientists can gain insights into fundamental biological processes and identify new therapeutic targets.

The synthesis of 2,6-Difluoro-4-hydroxybenzyl alcohol typically involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include halogenation followed by selective reduction or nucleophilic substitution reactions. Advanced techniques such as transition-metal-catalyzed cross-coupling reactions have also been employed to enhance synthetic efficiency. These methodologies underscore the compound's significance as a versatile intermediate in modern synthetic chemistry.

The growing interest in fluorinated compounds has spurred innovation in synthetic methodologies tailored to their specific requirements. For instance, recent advancements in flow chemistry have enabled scalable production of complex fluorinated intermediates like 2,6-Difluoro-4-hydroxybenzyl alcohol, addressing challenges associated with traditional batch processing. Such innovations not only improve production efficiency but also enhance safety by minimizing solvent usage and reducing waste generation.

Beyond pharmaceutical applications, 2,6-Difluoro-4-hydroxybenzyl alcohol holds potential in other areas of chemical biology. Its ability to interact with biological targets makes it a valuable tool for developing imaging agents or probes used in diagnostic assays. Researchers are exploring its use in fluorescence-based assays where its structural features contribute to enhanced signal detection and specificity.

The impact of fluorine substitution on molecular properties underscores the importance of understanding structure-activity relationships (SAR) when designing new drug candidates. 2,6-Difluoro-4-hydroxybenzyl alcohol serves as a prime example of how strategic introduction of fluorine atoms can significantly alter biological activity while maintaining desirable pharmacokinetic profiles. This principle is fundamental to rational drug design approaches that aim to maximize therapeutic efficacy while minimizing side effects.

In conclusion,2,6-Difluoro-4-hydroxybenzyl alcohol (CAS No: 438049-36-6) represents a fascinating compound with broad applications across pharmaceutical chemistry and biomedicine. Its unique structural features—combining fluoroaromatic stability with reactive hydroxyl functionality—make it an invaluable intermediate for drug discovery efforts targeting various diseases. As research continues to uncover new therapeutic opportunities,2,6-Difluoro-4-hydroxybenzyl alcohol is poised to play an increasingly significant role in shaping next-generation therapeutics.

• 56456-47-4((2,4-difluorophenyl)methanol)
• 89735-30-8(1,2-Benzenediol, 4-fluoro-5-(hydroxymethyl)-)
• 79538-27-5(2,6-Difluoro-4-methoxybenzyl alcohol)
• 405-09-4((2-Fluoro-4-methoxyphenyl)methanol)
• 61596-38-1(Benzenemethanol, 2,3,5,6-tetrafluoro-4-hydroxy-)
• 504414-33-9(Benzenemethanol, 2-fluoro-4-(phenylmethoxy)-)
• 118289-07-9(2,4,6-Trifluorobenzyl Alcohol)
• 19064-18-7(2,6-Difluorobenzyl alcohol)
• 452-78-8(3-Fluoro-4-methylphenol)
• 89735-28-4(1,2-Benzenediol, 3-fluoro-4-(hydroxymethyl)-)